Suppression of bone remodeling associated with long-term bisphosphonate treatment is mediated by microRNA-30a-5p
Oral bisphosphonates (BPs) are a first-line treatment for osteoporosis. It is becoming a hot topic to identify new indicators for the early prediction of therapeutic effects and adverse reactions during the long-term use of BPs. To determine whether microRNA (miRNA) expression is modulated by long-t...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Taylor and Francis Ltd.
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |